Conquering Diseases

Study Of An Investigational Drug To Help Reduce Substance Use For People With Schizophrenia

Description

Seeking men and women who have been diagnosed with schizophrenia or schizoaffective disorder and a substance use disorder for a study of an anti-psychotic medication to see it helps reduce substance cravings.

Overview

We are studying whether an FDA approved anti-psychotic can help reduce substance use in individuals diagnosed with schizophrenia or schizoaffective disorder. Some recent studies have shown that drugs similar to brexpiprazole can help reduce substance craving and have been used with patients who have schizophrenia.

What we're hoping for

Evaluate whether the investigational drug is safe and effective for reducing substance use in people diagnosed with schizophrenia or schizoaffective disorder.

Additional Information

ClinicalTrials.gov Identifier: NCT03526354

 Principal Investigator

Xiaoduo  Fan, MD

University of Massachusetts Medical School

 Study Contact

Alyssa  Christopher

508-856-8327

Alyssa.Christopher@umassmed.edu

 Location

UMMHC Community Healthlink, Inc.

72 Jaques Ave. 

Worcester,MA 01610

508-860-1000